17 C
Lucknow
March 5, 2024
The Hona News
health

Study shows clinical benefit of a new way of treating advanced ER+ breast cancer



A research paper published today in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator that stimulates the male sex hormone receptor, has anti-tumor effects in estrogen receptor-positive breast cancer patients.



Source link

Related posts

New cell-based immunotherapy offered for melanoma

asdavi92

Significant proportion of cancer drugs lack proof of added benefit, finds study

asdavi92

Drug limits dangerous reactions to allergy-triggering foods, pediatric study finds

asdavi92

Leave a Comment